Zuzana Diamant to Asthma
This is a "connection" page, showing publications Zuzana Diamant has written about Asthma.
Connection Strength
1.178
-
Revisiting matrix metalloproteinase 12: its role in pathophysiology of asthma and related pulmonary diseases. Curr Opin Pulm Med. 2021 01; 27(1):54-60.
Score: 0.229
-
Precision medicine and treatable traits in chronic airway diseases - where do we stand? Curr Opin Pulm Med. 2020 01; 26(1):33-39.
Score: 0.213
-
Toward effective prescription of inhaled corticosteroids in chronic airway disease. Int J Chron Obstruct Pulmon Dis. 2018; 13:3419-3424.
Score: 0.196
-
Summing up 100 years of asthma. Respir Med. 2007 Mar; 101(3):378-88.
Score: 0.087
-
Asthma and severe acute respiratory syndrome coronavirus 2019: current evidence and knowledge gaps. Curr Opin Pulm Med. 2021 01; 27(1):45-53.
Score: 0.057
-
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions. Eur Respir J. 2019 09; 54(3).
Score: 0.052
-
Personalized Approach to Severe Asthma. Biomed Res Int. 2018; 2018:2465172.
Score: 0.050
-
ERS technical standard on bronchial challenge testing: pathophysiology and methodology of indirect airway challenge testing. Eur Respir J. 2018 11; 52(5).
Score: 0.049
-
Towards precision medicine in severe asthma: Treatment algorithms based on treatable traits. Respir Med. 2018 09; 142:15-22.
Score: 0.048
-
Targeting the interleukin-4 and interleukin-13 pathways in severe asthma: current knowledge and future needs. Curr Opin Pulm Med. 2018 01; 24(1):50-55.
Score: 0.046
-
Assessing patient-reported outcomes in asthma and COPD patients: which can be recommended in clinical practice? Curr Opin Pulm Med. 2018 01; 24(1):18-23.
Score: 0.046
-
Club cell protein (CC16) in plasma, bronchial brushes, BAL and urine following an inhaled allergen challenge in allergic asthmatics. Biomarkers. 2018 Feb; 23(1):51-60.
Score: 0.046
-
Toll-like receptor 3 blockade in rhinovirus-induced experimental asthma exacerbations: A randomized controlled study. J Allergy Clin Immunol. 2018 04; 141(4):1220-1230.
Score: 0.045
-
Comparing biologicals and small molecule drug therapies for chronic respiratory diseases: An EAACI Taskforce on Immunopharmacology position paper. Allergy. 2019 03; 74(3):432-448.
Score: 0.012